Relaxin-2 is a novel biomarker for differentiated thyroid carcinoma in humans - Kotwal, Anupam; Simpson, Ronda; Whiteman, Nicholas; Swanson, Benjamin; Yuil-Valdes, Ana; Fitch, Madelyn; Nguyen, Joshua; Elhag, Salma; Shats, Oleg; Goldner, Whitney; Bennett, Robert (Biochemical pharmacology, 2024)
Keywords: Adult; Aged; Antigens, CD - genetics; Antigens, CD - metabolism; Antigens, Differentiation, Myelomonocytic - genetics; Antigens, Differentiation, Myelomonocytic - metabolism; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Carcinogenesis; Cell Line, Tumor; Female; Humans; Macrophages; Male; Middle Aged; Receptors, G-Protein-Coupled - genetics; Receptors, G-Protein-Coupled - metabolism; Receptors, Peptide - genetics; Receptors, Peptide - metabolism; Relaxin; Relaxin - genetics; Relaxin - metabolism; Thyroid carcinoma; Thyroid Neoplasms - diagnosis; Thyroid Neoplasms - genetics; Thyroid Neoplasms - metabolism; Thyroid Neoplasms - pathology; Tumor microenvironment; RET; RNA; PDTC; HRP; PTEN; DNase; Macrophages; Carcinogenesis; Thyroid carcinoma; STR; SD; TPOAb; NRAS; TNM; FFPE; RLN; AJCC; qPCR; GUSB; INSL; HRAS; TSA; TBP; DAB; TBS; Tumor microenvironment; TMA; BRAF; EDTA; TME; Relaxin; ATA; ECM; Tris; ATC; MMP; DTC; iCaRe2; DNA; RXFP; TTBS; IRB; TCCR; GAPDH; TP53; PCR; PTC; TIMP